Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119,358,581
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
36,846,465
-
Shares change
-
-1,570,116
-
Total reported value, excl. options
-
$265,286,731
-
Value change
-
-$12,318,500
-
Put/Call ratio
-
64%
-
Number of buys
-
48
-
Number of sells
-
-58
-
Price
-
$7.20
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q1 2018
142 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q1 2018.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36,846,465 shares
of 119,358,581 outstanding shares and own 31% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7,257,257 shares), BVF INC/IL (5,721,888 shares), VANGUARD GROUP INC (3,393,643 shares), LANSDOWNE PARTNERS (UK) LLP (2,647,981 shares), STATE STREET CORP (2,361,612 shares), FMR LLC (2,292,452 shares), WELLINGTON MANAGEMENT GROUP LLP (2,020,256 shares), WASATCH ADVISORS INC (1,761,882 shares), PINNACLE ASSOCIATES LTD (888,415 shares), and CITIGROUP INC (772,321 shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.